Navigation Links
EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Date:8/19/2007

Third Phase II Trial Initiated by Myriad For Azixa(TM)

TARRYTOWN, N.Y., Aug. 17 /PRNewswire-FirstCall/ -- EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today reported on new clinical advancements for Azixa(TM)* (MPC-6827), a vascular disrupting agent licensed by the Company to Myriad Genetics, Inc. as part of an exclusive, worldwide development and commercialization agreement.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020513/NYM112LOGO )

Myriad announced yesterday that it has initiated a third Phase II clinical trial for Azixa in patients with non-small-cell lung cancer that has spread to the brain. The trial is designed to assess Azixa's safety profile and the extent to which it can improve the overall survival of these patients. Two additional Phase II trials for Azixa are underway in primary brain cancer and melanoma that has spread to the brain.

"We are pleased at the clinical advancement Myriad has reported on Azixa, and view it as further evidence of the commercial potential of the compound," stated Jack Talley, President and Chief Executive Officer. "We believe that the study of Azixa in this new indication affords EpiCept with an expanded opportunity to capitalize on the financial benefits associated with our agreement with Myriad, including milestone payments, sublicensing income and potentially future royalties if Azixa continues to progress successfully."

Myriad is responsible for the worldwide development and commercialization of Azixa and any drug candidate that is developed from the series of compounds licensed by EpiCept to Myriad in 2003. The agreement requires that Myriad make future licensing, research and milestone payments to EpiCept, as well as pay a portion of any sublicensing income and pay a royalty on product sales. EpiCept will earn a milestone payment upon the dosing of the first patient in a Phas
'/>"/>

SOURCE EpiCept Corporation

Copyright©2007 PR Newswire.

1

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. EpiCept Corporation to Present New NP-1 Data at American Pain Society Meeting
2. Mode of Action of EpiCept-Licensed Cancer Compound Profiled at AACR
3. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
4. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
5. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
6. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
7. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
8. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
9. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
10. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
11. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...idgePointMedicalannouncedtodaythatitreceivedEurope...pheralChronicTotalOcclusion(CTO)CrossingSystemcomp...ingray®CTORe-EntrySystem.TheBridgePointSystem...onavigatehighlydiseasedarteriesinpreparationforblo...TheNationalHeart,LungandBloodInstitute(NHLBI)estim...
(Date:11/23/2009)...-LightSciencesOncology,Inc.(LSO)todayannouncedthee...anewlycreatedseatonitsboardofdirectors.Mr.Seddighi...nies,includingElekta,tomarketleadership. ,, "Th...inbusinessdevelopmenttotheboard,"saidLSO,sChairman...ancer-therapybusinessdevelopment.Hehasoverseenthee...
(Date:11/23/2009)...re-FirstCall/-- LexiconPharmaceuticals,Inc. (Nasda...se2clinicalstudywith LX1031 inpatientswithnon-cons...atGASTRO2009inLondonthisweek.Resultsfromthestudy,w...lbepresentedbyDr. PhilipM.Brown ,Lexicon,sseniorvi...at2:30pmlocaltimeatthesessionentitled,"Therapeutic...
Breaking Medicine Technology:BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries 2Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Protein plays unexpected role protecting chromosome tips 54456 1Protein plays unexpected role protecting chromosome tips 54456 2Protein plays unexpected role protecting chromosome tips 54456 3Canadian scientists identify gene that makes water striders glide across water 9567 1Brain innately separates living and non living objects for processing 9565 1Brain innately separates living and non living objects for processing 9565 2
...ATERTOWN, Mass.--(BUSINESS WIRE)--May 29, 2007 - P...echnology company,dedicated to developing the next...ay announced the results of a new study,indicating...y have,reduced potential for the development of re... in laboratory assays. The study,carried out by s...
...REHOVOT, Israel, May 29, 2007 /PRNewswire/ -- D-Ph...IIb trial for its,neuroprotective compound DP-b99 ... will be presented at the European Stroke,Conferen...an,principal investigator Prof. H. C. Diener, on T...he Scottish Exhibition Conference,Center in Glasgo...
Other Medicine Technology:Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have,Reduced Potential to Develop Resistance to Panacos' Bevirimat 2Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have,Reduced Potential to Develop Resistance to Panacos' Bevirimat 3DP-b99 Phase IIb Trial Results to be Presented at the European,Stroke Conference 2DP-b99 Phase IIb Trial Results to be Presented at the European,Stroke Conference 3
(Date:11/23/2009)... Same Day STD Testing now provide... all types of STD,s, including Chlamydia, Herpes, ...l done anonymously. , (PR...nd on the web at: http://www.samedaystdtesting.co...l STD testing, which is now available to accuratel...
(Date:11/23/2009)...HATBORO,Pa.,Nov.23/PRNewswire-FirstCall/--InfoLogi...enterprisemobilitysolutionsforthehealthcareandcomm...cePresidentofManagedServicesatSiemensHealthService...thcareServices. ,, (Logo: http://www.newscom.co...PresidentofStrategicHealthcareServicesforInfoLogix...
(Date:11/23/2009)...ND, Ore. Low-income children who don,t access hea...long term are significantly more likely to have un...rding to a new study published in the journal Ped...forming the financing and delivery of quality heal... "In the current policy debates about health insur...
(Date:11/23/2009)...hips doubled number of patients who reined in thei..., Nov. 23 (HealthDay News) -- High blood pressure ...rking hand-in-hand than by doctors and pharmacists...icians work with pharmacists, medications are inte...effectively," said Barry L. Carter, a professor in...
(Date:11/23/2009)... PartnershipswithMinorityBanksin Washington D.... and Columbia , S.C. IntendedtoSpurEconomicGro...wswire-USNewswire/--DaVita,thenation,sleadingprovi...orityBankInitiativedesignedtocreatejobsandspurrevi...hinvestmentsinleadingcommunityandminority-ownedban...
Breaking Medicine News(10 mins):Health News:100% Anonymous, Confidential and Quick STD Screening Now Available with Same Day STD Testing 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3Health News:Children who lack continuity with a regular health care provider miss needed services 2Health News:Children who lack continuity with a regular health care provider miss needed services 3Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 2Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 3Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 2Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 3
...6). Senior Editor David J. Jefferson writes,about ...es from Ulysses S.,Grant High School, class of ,82...ntimate interviews with former classmates, Jeffers...growing up.,"Although I grew up a few blocks from ...
... Hundreds of,Service Employees International Union...protest tonight, renouncing recent actions by the,...n other unions,organizing efforts. SEIU members ma... cancelled at the last minute,anticipating the scr...
... areas with older, poorer, less educated populatio...e on charity for end-of-life care , ANN ARBOR, Mi...the care of a hospice service, a huge increase fro...ce care across the country gaps that the research...
...Broken Promises Make Pregnancy and Childbirth #1,K...11 The White Ribbon,Alliance for Safe Motherhood ... Monetary Fund and World Bank to drastically incre...ly to,be met in Asia until 2076 and many years lat...
...ealthcare Services,Inc. (NYSE: AHS ), the largest... will host its quarterly conference call to discus... at 5:00 p.m. Eastern Time. The company,expects to...hrough AMN Healthcare,s,website at http://www.amn...
...e higher rates of depression than other Hispanics ...udy by researchers at Hebrew SeniorLifes Institute... Puerto Ricans, who make up 11 percent of the Hisp...rica. Only 2.8 percent of Mexican Americans (46.7 ...
Other Medicine News:Health News:NEWSWEEK: Media Lead Sheet/April 21, 2008 Issue (on newsstands Monday, April 14). 2Health News:NEWSWEEK: Media Lead Sheet/April 21, 2008 Issue (on newsstands Monday, April 14). 3Health News:NEWSWEEK: Media Lead Sheet/April 21, 2008 Issue (on newsstands Monday, April 14). 4Health News:NEWSWEEK: Media Lead Sheet/April 21, 2008 Issue (on newsstands Monday, April 14). 5Health News:SEIU Members Stand Up for the Future of the Labor Movement and the Interests of All Workers 2Health News:National hospice study reveals gaps in service 2Health News:National hospice study reveals gaps in service 3Health News:National hospice study reveals gaps in service 4Health News:White Ribbon Alliance Calls for International Monetary Fund and World Bank to Invest in Women's Health 2Health News:AMN Healthcare Services to Host 2008 First Quarter Earnings Conference Call on Wednesday, May 7, 2008 2Health News:Researchers find disparities in depression among older Hispanics in US 2
...t androgen secreted into the blood. In males, test...ls of the testes; in females ca. 50% of circulatin...sion of androstenedione, ca. 25% from the ovary an...e ELISA KIT is based on the competition principle ...
Microalbumin Turbidimetric Lipid / Protein Quantification 021-SDX001
...etric assay (EIA) in the microplate format with a ...tative measurement of cortisol in serum. The micro...alibrators and patient samples are added to anti-r...icortisol,antibodies and ligand-labeled cortisol...
Vitamin B6 Jumbo REA Vitamin Assays, Cardiovascular 001-RK-VB6N
Medicine Products: